Recent Updates
Recently added Catalysts
AMN

Amy C. Chang Vice President, Investor Relations 866.861.3229 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2013 RESULTS Reports quarterly revenue of $252 million, up 11% year-over-year Diluted EPS of $0.16 vs. $0.07 fr

Key Takeaway: AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2013 RESULTS Reports quarterly revenue of $252 million, up 11% year-over-year Diluted EPS of $0.16 vs. $0.07 from continuing operations in prior year SAN DIEGO (May 2, 2013) AMN Healthcare Services, Inc. (NYSE: AHS), healthcare s innovato

Full Press Release Details

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2013 RESULTS
Reports quarterly revenue of $252 million, up 11% year-over-year
Diluted EPS of $0.16 vs. $0.07 from continuing operations in prior year
SAN DIEGO (May 2, 2013) AMN Healthcare Services, Inc. (NYSE: AHS), healthcare s innovator in workforce solutions and staffing
services, today announced first quarter 2013 financial results which exceeded the Company s guidance for both revenue and adjusted EBITDA. Financial highlights are as follows:
Dollars in millions, except per share amounts.*
Q1 2013 % Chg Q1 2012
Revenue $252.1 11%
Gross profit $73.0 15%
Net income $7.6 119%
Diluted EPS $0.16 129%
Adjusted EBITDA** $21.1 21%
AMN s first quarter performance, with year-over-year revenue growth and improved operating leverage across all business
segments, was driven by the team s strong execution and solid market demand trends, said Susan R. Salka, President and Chief Executive Officer of AMN Healthcare. As our clients continue to navigate through the transformational
trends in healthcare, our clear position as the leader in delivering innovative workforce solutions is enabling AMN to be a more strategic partner. Our pipeline of MSP opportunities remains strong, and we anticipate continued MSP penetration across
the nursing, allied and locum tenens staffing markets.
First Quarter 2013 Results
First quarter 2013 consolidated revenue was $252 million, an increase of 11% from the same quarter last year and 2% sequentially. First
quarter revenue for the Nurse and Allied Healthcare Staffing segment was $177 million, up 15% from the same quarter last year and 1% sequentially. Locum Tenens Staffing segment revenue in the first quarter was $65 million, an increase of 3% from the
same quarter last year and 4% sequentially. First quarter Physician Permanent Placement Services segment revenue was $10 million, an increase of 10% from the same quarter last year and a decrease of 2% sequentially.
First quarter gross margin of 29.0% was higher by 110 basis points than the same quarter last year and 50 basis points sequentially. The
increase over the prior year was due primarily to a favorable workers compensation reserve adjustment in the Nurse and Allied Healthcare Staffing segment and a gross margin improvement in the Locum Tenens Staffing segment. The sequential
increase was driven by the favorable workers compensation reserve adjustment.
SG&A expenses for the first quarter
were $54 million, representing 21.3% of revenue, compared to 20.8% of revenue in the same quarter last year and 21.4% of revenue in the prior quarter. The increase from the prior year was due primarily to higher spending in support of revenue growth
and a prior year $2 million refund received in connection with the settlement of an assessment with the California Employment Development Department partially offset by improved operating leverage.
First quarter adjusted EBITDA grew 21% year-over-year to $21 million. Adjusted EBITDA margin
of 8.4% represented a 70 basis point increase over the prior year and was driven by improvements in gross margin and operating leverage. First quarter net income was $8 million. First quarter net income per diluted common share was $0.16.
As of March 31, 2013, cash and cash equivalents totaled $2 million and total term debt outstanding, net of discount, was
$158 million, with a leverage ratio of 2.3 to 1. First quarter 2013 cash used in operations was $3 million, driven by an increase in working capital from higher days sales outstanding. Capital expenditures were $2 million.
The Company s amendment to its credit agreement went into effect on April 9, 2013, reducing the interest rate on the revolving
line of credit and term loan.
Business Trends and Outlook
The Company expects second quarter consolidated revenue to be between $251 million and $255 million, representing year-over-year revenue
growth of 6% to 8%. Gross margin is expected to be approximately 28.5%. SG&A expenses as a percentage of revenue are expected to be approximately 21.0% to 21.5%. Adjusted EBITDA margin is expected to be approximately 7.5% to 8.0%.
About AMN Healthcare
AMN Healthcare is the innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare s workforce solutions including managed
services programs and recruitment process outsourcing enable providers to successfully reduce complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. The Company provides unparalleled
access to the largest network of quality clinicians and physicians through its innovative recruitment strategies
and breadth of career opportunities. Clients include acute-care hospitals, government facilities, community health centers and clinics, physician practice groups and many other healthcare
settings. For more information, visit http://www.amnhealthcare.com.
Conference Call on May 2, 2013
AMN Healthcare Services, Inc. s first quarter 2013 conference call will be held on Thursday, May 2, 2013, at 5:00 p.m. Eastern Time. A live
webcast of the call can be accessed through AMN Healthcare s website at http://amnhealthcare.investorroom.com/presentations. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software.
Interested parties may participate live via telephone by dialing (800) 288-9626 in the U.S. or (612) 332-0634 internationally. Following the conclusion of the call, a replay of the webcast will be available at the Company s website. A
telephonic replay of the call will also be available at 7:30 p.m. Eastern Time on May 2, 2013, and can be accessed until 2:59 a.m. Eastern Time on May 17, 2013, by calling (800) 475-6701 in the U.S. or (320) 365-3844
internationally, with access code 287506.
This earnings release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company s consolidated financial
statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, and (2) adjusted EBITDA margin. The Company provides such non-GAAP financial measures because management believes that they are
useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company s operating performance. Additionally, management believes that adjusted EBITDA and adjusted EBITDA margin serve as industry-wide
financial measures, and it uses adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP, and may be different from non-GAAP measures, or
may be calculated differently than other similarly title captioned non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company s performance. A reconciliation of non-GAAP measures identified in
this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled Supplemental Financial and Operating Data under the caption entitled Reconciliation of
Non-GAAP Items or on the Company s website at http://amnhealthcare.investorroom.com/financialreports.
time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company s website.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include expectations regarding 2013 second quarter revenue,
margin, SG&A expenses, adjusted EBITDA margin and continued MSP penetration. The Company based these forward-looking statements on its current expectations, estimates and projections about
future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are
identified by words such as believe, anticipate, expect, intend, plan, will, may, estimates, variations of such words and other similar expressions. In
addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking
statements contained in this press release are set forth in the Company s Annual Report on Form 10-K for the year ended December 31, 2012 and its other periodic reports as well as the Company s current and other reports filed from
time to time with the Securities and Exchange Commission. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated with the passage of time.
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Comprehensive Income
(in thousands, except per share amounts)
Three Months Ended
March 31, December 31,
2013 2012 2012
Revenue $ 252,120 $ 226,412 $ 247,841
Cost of revenue 179,113 163,198 177,214
Gross profit 73,007 63,214 70,627
29.0 % 27.9 % 28.5 %
Operating expenses:
Selling, general and administrative 53,607 47,176 53,049
21.3 % 20.8 % 21.4 %
Depreciation and amortization 3,290 3,695 3,469
Total operating expenses 56,897 50,871 56,518
Income from operations 16,110 12,343 14,109
Interest expense, net 2,859 5,533 3,208
Income from continuing operations before income taxes 13,251 6,810 10,901
Income tax expense 5,688 3,357 3,818
Income from continuing operations 7,563 3,453 7,083
Income from discontinued operations, net of tax 0 823 0
Net income $ 7,563 $ 4,276 $ 7,083
Basic income per common share from:
Continuing operations $ 0.17 $ 0.07 $ 0.16
Discontinued operations 0.00 0.02 0.00
Net income $ 0.17 $ 0.09 $ 0.16
Diluted income per common share from:
Continuing operations $ 0.16 $ 0.07 $ 0.15
Discontinued operations 0.00 0.02 0.00
Net income $ 0.16 $ 0.09 $ 0.15
Weighted average common shares outstanding:
Basic 45,813 40,576 44,270
Diluted 47,679 46,164 47,296
Other comprehensive income (loss) 93 (43 ) (5 )
Comprehensive income $ 7,656 $ 4,233 $ 7,078
AMN Healthcare Services, Inc.
Supplemental Financial and Operating Data
(dollars in thousands, except operating data)
Three Months Ended
March 31, December 31,
2013 2012 2012
Revenue
Nurse and allied healthcare staffing $ 176,765 $ 153,886 $ 174,997
Locum tenens staffing 65,456 63,509 62,739
Physician permanent placement services 9,899 9,017 10,105
$ 252,120 $ 226,412 $ 247,841
Reconciliation of Non-GAAP Items:
Segment operating income(1)
Nurse and allied healthcare staffing $ 22,474 $ 17,077 $ 21,601
Locum tenens staffing 4,892 4,416 4,808
Physician permanent placement services 2,241 1,706 2,071
29,607 23,199 28,480
Unallocated corporate overhead 8,505 5,732 9,256
Adjusted EBITDA(2) 21,102 17,467 19,224
Adjusted EBITDA margin(3) 8.4 % 7.7 % 7.8 %
Depreciation and amortization 3,290 3,695 3,469
Stock-based compensation 1,702 1,429 1,646
Interest expense, net 2,859 5,533 3,208
Income from continuing operations before income taxes 13,251 6,810 10,901
Income tax expense 5,688 3,357 3,818
Net income from continuing operations 7,563 3,453 7,083
Net income from discontinued operations 0 823 0
Net income $ 7,563 $ 4,276 $ 7,083
Three Months Ended
March 31, December 31,
2013 2012 2012
Gross Margin
Nurse and allied healthcare staffing 27.5 % 26.4 % 26.6 %
Locum tenens staffing 27.9 % 27.1 % 28.0 %
Physician permanent placement services 62.6 % 59.5 % 65.2 %
Operating Data:
Nurse and allied healthcare staffing
Average clinicians on assignment (4) 6,215 5,443 6,075
Revenue per clinician per day(5) $ 316.02 $ 310.68 $ 313.11
Gross profit per clinician per day(5) $ 86.80 $ 81.99 $ 83.17
Locum tenens staffing
Days filled (6) 45,357 45,990 44,377
Revenue per day filled(6) $ 1,443.11 $ 1,380.93 $ 1,413.77
Gross profit per day filled(6) $ 402.62 $ 374.92 $ 395.50
As of March 31 As of December 31,
2013 2012 2012
Leverage ratio (7) 2.3 3.2 2.4
AMN Healthcare Services, Inc.
Condensed Consolidated Balance Sheets
(dollars in thousands)
March 31, 2013 December 31, 2012
Assets
Current assets:
Cash and cash equivalents $ 1,939 $ 5,681
Accounts receivable, net 156,750 142,510
Accounts receivable, subcontractor 19,332 18,467
Deferred income taxes, net 17,794 18,123
Prepaid and other current assets 21,399 18,963
Total current assets 217,214 203,744
Restricted cash, cash equivalents and investments 18,801 18,861
Fixed assets, net 15,336 14,815
Deposits and other assets 21,186 19,732
Goodwill 123,324 123,324
Intangible assets, net 135,304 136,910
Total assets $ 531,165 $ 517,386
Liabilities and stockholders equity
Current liabilities:
Accounts payable and accrued expenses $ 56,721 $ 52,619
Accrued compensation and benefits 49,393 49,443
Revolving credit facility 1,000 0
Other current liabilities 7,056 7,463
Total current liabilities 114,170 109,525
Notes payable, less current portion and discount 158,246 158,178
Other long-term liabilities 67,279 67,572
Total liabilities 339,695 335,275
Commitments and contingencies
Stockholders equity 191,470 182,111
Total liabilities and stockholders equity $ 531,165 $ 517,386
AMN Healthcare Services, Inc.
Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
Three Months Ended
March 31, December 31,
2013 2012 2012
Net cash (used in) provided by operating activities $ (2,699 ) $ 9,553 $ 18,450
Net cash (used in) provided by investing activities (2,155 ) 7,352 (1,257 )
Net cash provided by (used in) financing activities 1,019 (15,923 ) (15,330 )
Effect of exchange rates on cash 93 (43 ) (5 )
Net (decrease) increase in cash and cash equivalents (3,742 ) 939 1,858
Cash and cash equivalents at beginning of period 5,681 3,962 3,823
Cash and cash equivalents at end of period $ 1,939 $ 4,901 $ 5,681
Last updated: May 2, 2013